Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-12 Gibson Christopher Chief Executive Officer Conversion +4,000 4,000
2023-07-12 Gibson Christopher Chief Executive Officer Sale −850 $10.82 $9K 3,150
2023-07-12 Gibson Christopher Chief Executive Officer Sale −2,173 $11.80 $26K 977
2023-07-12 Gibson Christopher Chief Executive Officer Sale −850 $12.41 $11K 127
2023-07-12 Gibson Christopher Chief Executive Officer Sale −127 $14.06 $2K 0
2023-07-12 Gibson Christopher Chief Executive Officer Conversion +20,000 20,000
2023-07-12 Gibson Christopher Chief Executive Officer Sale −4,430 $10.84 $48K 15,570
2023-07-12 Gibson Christopher Chief Executive Officer Sale −10,327 $11.74 $121K 5,243
2023-07-12 Gibson Christopher Chief Executive Officer Sale −4,693 $12.41 $58K 550
2023-07-12 Gibson Christopher Chief Executive Officer Sale −550 $14.03 $8K 0
2023-07-12 Gibson Christopher Chief Executive Officer Conversion +1,000 1,000
2023-07-12 Gibson Christopher Chief Executive Officer Sale −236 $10.87 $3K 764
2023-07-12 Gibson Christopher Chief Executive Officer Sale −561 $11.82 $7K 203
2023-07-12 Gibson Christopher Chief Executive Officer Sale −127 $12.36 $2K 76
2023-07-12 Gibson Christopher Chief Executive Officer Sale −63 $13.75 $867 13
2023-07-12 Gibson Christopher Chief Executive Officer Sale −13 $14.85 $193 0
2023-07-12 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −31,250 562,500
2023-07-12 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −4,000 527,000
2023-07-12 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −20,000 468,000
2023-07-12 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −1,000 121,875

Page 36 of 41 · 805 trades